RemeGen (688331.SS) Earnings Analysis
RemeGen (688331.SS) next reports earnings on 2026-08-25. Trailing P/E 54.64.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688331.SS next report earnings?
| Next earnings date | 2026-08-25 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
688331.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-28 | 2.24 CNY | n/a | n/a | n/a |
| 2025-10-30 | -0.18 CNY | n/a | n/a | n/a |
| 2025-08-22 | -0.36816 CNY | n/a | n/a | n/a |
| 2025-04-24 | -0.47366 CNY | n/a | n/a | n/a |
| 2025-02-27 | -0.73978 CNY | n/a | n/a | n/a |
| 2024-08-16 | -0.7996 CNY | n/a | n/a | n/a |
688331.SS valuation and analyst view
| Trailing P/E | 54.64 |
|---|---|
| Trailing EPS | 2.307 CNY |
| Price / book | 17.74 |
| Dividend yield | 0.00% |
| Market cap | 70.23B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is RemeGen (688331.SS)'s next earnings date?
RemeGen is next scheduled to report on 2026-08-25.
Did 688331.SS beat earnings last quarter?
Consensus estimate data was not available for 688331.SS's 2026-02-28 report.
What is 688331.SS's current P/E ratio and EPS?
688331.SS trades at a trailing P/E of 54.64 on trailing EPS of 2.30726018443346 CNY.
What do analysts rate 688331.SS?
688331.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.